Advertisement

How herd immunity will help us fight COVID-19

×

Herd immunity occurs when a large percentage of a population is immune to an infectious disease. There are two ways to achieve it: by exposing a large percentage of the population to a virus, or by producing a vaccine.

By Jackeline Luna ,

Maggie Beidelman

May 5, 2020

12:33 PM

Science

Get our free Coronavirus Today newsletter

Sign up for the latest news, best stories and what they mean for you, plus answers to your questions.

You may occasionally receive promotional content from the Los Angeles Times.

Jackeline Luna

Follow Us

Jackeline Luna is a video journalist. Before joining the Los Angeles Times, she interned for Politico, ABC7 and The Mercury News. She graduated from UC Berkeley with a master’s in journalism in May 2018.

Maggie Beidelman

Follow Us

Maggie Beidelman is a senior video director focusing on the L.A. Times’ YouTube channel. Before joining the Los Angeles Times, Beidelman helped launch AJ+, the digital media channel of Al Jazeera Media Network, where she produced the award-winning series “Untold America.” Beidelman has her master’s in documentary film from the UC Berkeley Graduate School of Journalism.

More From the Los Angeles Times

Science

Dangerous blood clots pose a perplexing coronavirus threat

Science

Dangerous blood clots pose a perplexing coronavirus threat

Blood clots that can cause strokes, heart attacks and blockages in the legs and lungs are increasingly being found in COVID-19 patients, including children.
California

Coronavirus ‘silent spreaders’ become a bigger risk as California reopens

California

Coronavirus ‘silent spreaders’ become a bigger risk as California reopens

There’s increasing concern that people infected with COVID-19 who show no signs of illness are playing a large role in the transmission of COVID-19.

More Coverage

Tracking the reopening process in California

Op-Ed: Will Memorial Day 2020 be remembered as the holiday when COVID-19 got the upper hand?
Science

U.N. virus therapy trial pauses hydroxychloroquine testing

Science

U.N. virus therapy trial pauses hydroxychloroquine testing

The World Health Organization says it will pause hydroxychloroquine testing during COVID-19 study so experts can review data on the antimalarial drug.
Science

What’s the link between the coronavirus and the Kawasaki-like disease MIS-C?

Science

What’s the link between the coronavirus and the Kawasaki-like disease MIS-C?

The coronavirus can trigger a rare but serious inflammatory response that health officials are calling multi-system inflammatory syndrome in children, or MIS-C.

Advertisement